Association between acute neuropsychiatric events and helicobacter pylori therapy containing clarithromycin

JAMA Internal Medicine

Volumn 176, Issue 6, 2016, Pages 828-834

  Wong, Angel Y S ^a   Wong, Ian C K ^a,b   Chui, Celine S L ^a   Lee, Edwin H M ^a   Chang, W C ^a   Chen, Eric Y H ^a   Leung, Wai K ^a   Chan, Esther W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SAFETY; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; NEUROLOGIC DISEASE; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; RAPID UREASE TEST; AFFECT; COMBINATION DRUG THERAPY; DELIRIUM; DRUG EFFECTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HONG KONG; OUTPATIENT; PSYCHOTIC DISORDERS; SLEEP WAKE DISORDERS;

ADULT; AFFECT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CASE-CONTROL STUDIES; CLARITHROMYCIN; DELIRIUM; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HONG KONG; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OUTPATIENTS; PROTON PUMP INHIBITORS; PSYCHOTIC DISORDERS; SLEEP WAKE DISORDERS;

EID: 84969799299     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.1586     Document Type: Article

References (45)

1. Ho P, Wong S. Reducing bacterial resistance with IMPACT. 4th ed. 2012. http://www.chp.gov.hk/files/pdf/reducing-bacterial-resistance-with-impact.pdf. Accessed September 7, 2015.
2. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection: The Maastricht IV/Florence Consensus Report. Gut. 2012;61(5):646-664.
3. Nightingale SD, Koster FT, Mertz GJ, Loss SD. Clarithromycin-induced mania in two patients with AIDS. Clin Infect Dis. 1995;20(6):1563-1564.
4. Pollak PT, Sketris IS, MacKenzie SL, Hewlett TJ. Delirium probably induced by clarithromycin in a patient receiving fluoxetine. Ann Pharmacother. 1995;29(5):486-488.
5. Steinman MA, Steinman TI. Clarithromycinassociated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1996;27(1):143- 146.
6. Cone LA, Sneider RA, Nazemi R, Dietrich EJ. Mania due to clarithromycin therapy in a patient who was not infected with human immunodeficiency virus. Clin Infect Dis. 1996;22(3): 595-596.
7. Finkenbine R, Gill HS. Case of mania due to prednisone-clarithromycin interaction. Can J Psychiatry. 1997;42(7):778.
8. Abouesh A, Hobbs WR. Clarithromycin-induced mania. Am J Psychiatry. 1998;155(11):1626.
9. Mermelstein HT. Clarithromycin-induced delirium in a general hospital. Psychosomatics. 1998;39(6):540-542.
10. Geiderman JM. Central nervous system disturbances following clarithromycin ingestion. Clin Infect Dis. 1999;29(2):464-465.
11. Tse KC, Li FK, Tang S, Lam MF, Chan TM, Lai KN. Delusion of worm infestation associated with clarithromycin in a patient on peritoneal dialysis. Perit Dial Int. 2001;21(4):415-416.
12. Jiménez-Pulido, Navarro-Ruiz A, Sendra P, Martínez-Ramírez M, Garcia-Motos C, Montesinos-Ros A. Hallucinations with therapeutic doses of clarithromycin. Int J Clin Pharmacol Ther. 2002;40(1):20-22.
13. Brooks JO III, Hoblyn JC. Secondary mania in older adults. Am J Psychiatry. 2005;162(11):2033- 2038.
14. Vicente de Vera C, García M, Pifarre Teixido R, Barbe F. Delirium induced by clarithromycin in a patient with community-acquired pneumonia. Eur Respir J. 2006;28(3):671-672.
15. Kouvelou E, Pourzitaki C, Aroni F, Papazisis G, Kouvelas D. Acute psychosis induced by clarithromycin in a healthy adult? J Clin Psychopharmacol. 2008;28(5):579-580.
16. Liu EY, Vasudev A. Mania induced by clarithromycin in a geriatric patient taking low-dose prednisone. Prim Care Companion CNS Disord. 2014;16(3):PCC.14l01626.
17. Bandettini di Poggio M, Anfosso S, Audenino D, Primavera A. Clarithromycin-induced neurotoxicity in adults. J Clin Neurosci. 2011;18(3):313-318.
18. Abouesh A, Stone C, Hobbs WR. Antimicrobial-induced mania (antibiomania): A review of spontaneous reports. J Clin Psychopharmacol. 2002;22(1):71-81.
19. Gómez-Gil E, García F, Pintor L, Martínez JA, Mensa J, de Pablo J. Clarithromycin-induced acute psychoses in peptic ulcer disease. Eur J Clin Microbiol Infect Dis. 1999;18(1):70-71.
20. Neff NE, Kuo G. Acute manic psychosis induced by triple therapy for H. pylori. J AmBoard Fam Pract. 2002;15(1):66-68.
21. Ortíz-Domínguez A, Berlanga C, Gutiérrez-Mora D. A case of clarithromycin-induced manic episode (antibiomania). Int J Neuropsychopharmacol. 2004; 7(1):99-100.
22. Htut Y, Kunanayagam S, Poi PJ. Clarithromycin induced psychosis. Med J Malaysia. 2006;61(2):263.
23. Shah M, Subhani M, Rizvon K, Mustacchia P. Transient psychotic episode induced by Helicobacter pylori triple therapy treatment. Case Rep Gastroenterol. 2012;6(2):381-386.
24. Feng Z, Huang J, Xu Y, Zhang M, Hu S. Dissociative disorder induced by clarithromycin combined with rabeprazole in a patient with gastritis. J Int Med Res. 2013;41(1):239-243.
25. Dinca EB, Skinner A, Dinca RV, Tudose C. The dangers of gastritis: A case of clarithromycinassociated brief psychotic episode. J Nerv Ment Dis. 2015;203(2):149-151.
26. Wong AY, Root A, Douglas IJ, et al. Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ. 2016; 352:h6926.
27. HAHO/ITD. Clinical Data Analysis & Reporting System (CDARS) User's Manual. 2nd ed. Hong Kong: Hospital Authority; 2003:3.
28. Hospital Authority. Hospital Authority: Introduction. 2015. http://www.ha.org.hk/visitor/ha-visitor-index.asp?Parent-ID=10004&Content-ID=10008&Ver=HTML. Accessed November 25, 2015.
29. Chan EW, Lau WC, Leung WK, et al. Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: A population-based study. Gastroenterology. 2015;149(3):586-95.e3.
30. Chui C, Chan E, Wong A, Root A, Douglas IJ, Wong IC. Association between oral fluoroquinolones and seizures: A self-controlled case series study. Neurology. In press.
31. Pratt N, Chan EW, Choi NK, et al. Prescription sequence symmetry analysis: Assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiol Drug Saf. 2015;24(8):858-864.
32. Roughead EE, Chan EW, Choi NK, et al. Variation in association between thiazolidinediones and heart failure across ethnic groups: Retrospective analysis of large healthcare claims databases in six countries. Drug Saf. 2015;38(9): 823-831.
33. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: The self-controlled case seriesmethod. Stat Med. 2006; 25(10):1768-1797.
34. Kuriyama A, Jackson JL, Doi A, Kamiya T. Metronidazole-induced central nervous system toxicity: A systematic review. Clin Neuropharmacol. 2011;34(6):241-247.
35. Khandheria M, Snook E, Thomas C. Psychotic episode secondary tometronidazole use. Gen Hosp Psychiatry. 2014;36(2):231.e3-231.e4.
36. Voth AJ. Possible association between metronidazole and agitated depression. Can Med Assoc J. 1969;100(21):1012-1013.
37. Mahl TC, Ummadi S. Metronidazole and mental confusion. J Clin Gastroenterol. 2003;36(4):373-374.
38. Targum SD. Treating psychotic symptoms in elderly patients. Prim Care Companion J Clin Psychiatry. 2001;3(4):156-163.
39. Oliver DJ. Hallucinations associated with amoxicillin? a case report. Practitioner. 1984;228 (1396):884.
40. Stell IM, Ojo OA. Amoxicillin-induced hallucinations: A variant of Hoigne's syndrome? Br J Clin Pract. 1996;50(5):279.
41. Alfonzo CA, Bobo WV, Almond MD. Not a usual suspect: Rabeprazole therapy presenting as a severe neuropsychiatric illness: case report. Int J Psychiatry Med. 2003;33(3):311-315.
42. Hanneken AM, Babai N, Thoreson WB. Oral proton pump inhibitors disrupt horizontal cell-cone feedback and enhance visual hallucinations in macular degeneration patients. Invest Ophthalmol Vis Sci. 2013;54(2):1485-1489.
43. Akter S, Hassan MR, Shahriar M, Akter N, Abbas MG, Bhuiyan MA. Cognitive impact after short-term exposure to different proton pump inhibitors: Assessment using CANTAB software. Alzheimers Res Ther. 2015;7(1):79.
44. Nau R, Sörgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;23(4):858-883.
45. Wallace RJ Jr, Brown BA, Griffith DE. Drug intolerance to high-dose clarithromycin among elderly patients. Diagn Microbiol Infect Dis. 1993;16 (3):215-221.